Shares of Sareum Holdings Plc (LON: SAR) today surged 38.3% despite the lack of major releases from the company as investors buy into the biotech company ahead of the UK government’s response regarding its COVID-19 grant application.
The company recently revealed that it has applied for a UK government grant to fund laboratory studies investigating the potential of Sareum’s TYK2/JAK1 inhibitors to address severe inflammatory responses and potentially fatal respiratory symptoms of Covid-19 and other viral infections.
It appears that investors are expecting a positive response to the company’s grant application, which is expected by end of this month.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Tim Mitchell, the firm’s CEO recently said: “Sareum has continued to make good progress with the preclinical development of our proprietary dual TYK2/JAK1 inhibitor programmes.”
Adding:
“Most recently, we have overcome an important formulation challenge with SDC-1801, which will now be advanced into the toxicology studies needed to complete our preparations for clinical trials.”
Sareum has also raised additional funding to be used in advancing its proprietary programmes towards clinical development and build a robust data package to support its ongoing partnerships.
Sareum holdings share price
Sareum Holdings shares today surged 38.3% to trade at 2.49p having rallied from Friday’s closing price of 1.8p.
People who read this also read:
